3rd DIA Cell and Gene Therapy Products Symposium in Japan

Teruhide Yamaguchi, PhD

Professor Director, Institute of Advance Medical and Engineering

Masafumi Onodera, MD, PhD

Director, Center of Gene Cell Therapy Promotion,

Operation and Issues of Cartagena Law in Japan

Masafumi Onodera, MD, PhD

National Center for Child Health and Development, Japan

Director, Center of Gene Cell Therapy Promotion,

Environmental Assessments and Shedding Studies for Gene Therapy Products in the US and Japan

Teruhide Yamaguchi, PhD

Kanazawa Institute of Technology, Japan

Professor Director, Institute of Advance Medical and Engineering

Clinical Trials with Vaccines based on Genetically Modified Organisms in Europe and USA

Myra Widjojoatmodjo, PhD

Janssen Vaccines & Prevention B.V., Netherlands

Director

Points to Consider for Environmental Risk Assessment of the Use of Living Modified Organisms; PMDA Perspectives on Type 1 Use Approval under “Cartagena Law”

Kazunobu Oyama, PhD

Daiichi Sankyo Company, Limited, Japan